Skepticism is overrated

Leo Kim, Ph.D
Career Paths
Biopharma Research
Rate this article:

The Dour and SourYes, that’s right. Those of us bred in academia, we are a bunch of pessimists. Or, at least industry people perceive us, so you’d better get used to a new norm if you are determined not to become an anachronism. Get it? No? Ok, here’s an example. Your company just completed a clinical trial. Data shows that drug treatment groups seem to be slightly better off than ...